| Financial Year |
March 31 2023 |
| Monetary Funds |
310,400,249.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
10,164,361.59 |
| Advances to Suppliers |
25,296,858.23 |
| Other Receivables |
99,179.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,202,866.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,576,702.94 |
| Total Current Assets |
370,740,218.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
68,846,558.75 |
| Fixed Assetes |
3,037,561.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
861,712.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,954,746.18 |
| Other Non-Current Assets |
23,336,067.75 |
| Sub-Total of Non-Current Assets |
105,499,390.78 |
| Total Assets |
476,239,609.13 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
285,898,000.00 |
| Accounts Payable |
31,190,580.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,238,326.16 |
| Taxes Payable |
263,559.11 |
| Interest Payable |
-- |
| Dividend Payable |
157,312.40 |
| Other payables |
55,516,198.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,828.57 |
| Other Current Liabilities |
1,551,989.99 |
| Sub-Total of Current Liabilities |
418,662,867.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
418,662,867.50 |
| Paid-In Capital(Or Share Stock) |
224,226,822.00 |
| Capital Surplus |
237,087,924.90 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-404,873,748.26 |
| Minority Stockholder's Interest |
-4,584.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
57,581,325.64 |
| Owner's Equity（Stockholder's Equity） |
57,576,741.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
476,239,609.13 |
